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Nanophotonics, and more speciﬁcally plasmonics, provides a rich toolbox for biomolecular sensing, since the engineered meta-
surfaces can enhance light–matter interactions to unprecedented levels. So far, biosensing associated with high-quality factor
plasmonic resonances has almost exclusively relied on detection of spectral shifts and their associated intensity changes. How-
ever, the phase response of the plasmonic resonances have rarely been exploited, mainly because this requires a more sophisti-
cated optical arrangement. Here we present a new phase-sensitive platform for high-throughput and label-free biosensing
enhanced by plasmonics. It employs speciﬁcally designed Au nanohole arrays and a large ﬁeld-of-view interferometric lens-free
imaging reader operating in a collinear optical path conﬁguration. This unique combination allows the detection of atomically
thin (angstrom-level) topographical features over large areas, enabling simultaneous reading of thousands of microarray elements.
As the plasmonic chips are fabricated using scalable techniques and the imaging reader is built with low-cost off-the-shelf con-
sumer electronic and optical components, the proposed platform is ideal for point-of-care ultrasensitive biomarker detection from
small sample volumes. Our research opens new horizons for on-site disease diagnostics and remote health monitoring.
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INTRODUCTION
Biosensing is one of the most sought-after applications in the ﬁeld of
nanophotonics because the enhanced light–matter interactions via
sub-wavelength conﬁnement and ampliﬁcation of optical near-ﬁelds
give access to unprecedented real-time, label-free and highly sensitive
optical signal transductions1–10. For example, nanoengineered plas-
monic devices have revolutionized the performance of traditional
Raman11,12, ﬂuorescent13 and infrared14 spectroscopy techniques
enabling extraction of essential data on complex molecular structures,
as well as single-molecule detection15. In particular, refractometric
plasmonic sensors, such as those based on surface plasmon resonance
(SPR)16 and localized-SPR (LSPR)17,18 effects, have opened up new
horizons in label-free optical biosensing, overcoming limitations of
cumbersome and time-consuming labeled approaches, such as
enzyme-linked immunosorbent assay and ﬂuorescence detection.
Moreover, the small-volume, near-ﬁeld resonant plasmonic modes
act as perfect probes to monitor minute local refractive index changes
caused by molecular-binding events on the sensor surface. Most
recently, facilitated by convenient far-ﬁeld spectral intensity-measuring
techniques, versatile on-chip plasmonic biosensors enabling clinically
relevant detection limits of various biomaterials, such as bacteria19,
viruses20, exosomes21 and proteins22, have been reported. Despite the
recent progress, several challenges still exist for nanoplasmonic sensor
technologies, including the need for simpliﬁed and robust optical
readout systems and mass-scalable nanostructured chips with low
manufacturing costs.
From a more applied perspective, on-site biosensing without
dedicated personnel and infrastructure is essential for the biomedical
community23–25. In particular, simple, robust and affordable bio-
detection technologies that can rapidly and quantitatively detect
multiple analytes within small sample volumes would not only beneﬁt
medical diagnostics but also other ﬁelds, such as food safety and
environmental surveillance26. Several attempts have been made to
engineer point-of-care (POC) biosensors that leverage
nanoplasmonics27–30. Most of these devices rely on amplitude
(intensity) interrogation in which a narrow-band illumination source,
such as a light-emitting diode (LED), is tuned to the plasmonic
resonance, and the intensity variations due to the spectral resonance
shifts that are induced by local refractive index changes are quantiﬁed
on an imaging sensor, for example, a cellphone camera31, among other
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techniques32–34. Although this mode of detection can achieve spectral
monitoring without the need for expensive and bulky spectrophot-
ometers, its detection capabilities are limited by the plasmonic
resonance mode properties, such as sensitivity to refractive index
and quality factor (Q-factor, inversely proportional to the bandwidth
of the mode) as well as the level of environmental and instrumental
noise. Moreover, they do not usually allow multiplexed and high-
throughput detection as the operational sensing area is limited either
by the optical beam, when microscopes are used for read-out, or the
size of the nanoplasmonic sensor, which is often small when fabricated
using time-consuming and sophisticated techniques.
An alternative optical signal transduction mechanism for sensing is
phase interrogation, which measures phase retardations of electro-
magnetic wavefronts. Using phase rather than intensity in optical
detection has improved microscopy of thin and transparent
objects35,36 and elucidated the crystal structures of atomically thin
layers in the ﬁeld of X-ray diffraction37, among many other
applications38. Phase-based detection was introduced into SPR tech-
nology by Kabashin et al39 to exploit phase shifts varying sharply at
plasmonic resonances, ﬁrst reported by Abeles et al40 Conventional
light sources suffer from high-intensity (amplitude) noise, which in
turn reduces the detection sensitivity of intensity-based plasmonic
sensors. Instead, phase detection allows for lower noise and versatile
signal-processing possibilities, such as spatial and temporal mapping
due to the inherent relative measurement of phase with respect to a
reference beam41. Moreover, in the traditional intensity-based setting,
sensing is done at wavelengths that correspond to the side slopes of
resonant modes rather than at center wavelengths where the intensity
varies minimally as the resonance shifts. Despite that, the side slopes of
the intensity spectrum change moderately when compared to the
abrupt change that the phase spectrum exhibits at the center of the
modes. Therefore, the phase response allows for superior refractive
index sensing42.
Within the context of phase interrogation, nanostructured plasmo-
nic surfaces are still mostly unexplored and their phase response
investigation is limited15,43,44. Recently, Kravets et al15 used an
ellipsometric spectrometer to probe the sharp phase transitions in
plasmonic metamaterials for biosensing. These conventional
ellipsometer-like optical readers utilize orthogonally polarized compo-
nents of the same beam as reference and signal in an oblique
reﬂectance setup. Alternatively, Junesh et al43 proposed to use an
interferometric substrate with an Al mirror layer in order to access the
phase information associated with the resonance modes of short-range
ordered nanohole arrays in transmission and extracted the phase data
from oscillating spectral interference patterns. The common drawback
of these techniques is that they cannot provide spatial information,
which is essential for high-throughput multiplexed biosensing.
Importantly, despite their advantages, these traditional spectrometer-
based optical setups are complex and bulky, thus limiting the use of
phase interrogation, especially for POC applications.
Differential interference contrast microscope, which uses sheared
beams, is a phase-reading technique that allows two-dimensional
phase mapping on a limited ﬁeld of view (FOV), but its precision
relies on critical alignment of lens and Wollaston–Nomarski angle-
shearing prism45. Similarly, interferometric scattering microscopy is a
label-free platform with high phase sensitivity that suffers from limited
FOV due to the use of high numerical aperture objectives46,47.
Recently, a novel phase-interrogating large FOV interferometric
microscope was introduced, offering ultrasensitive axial topographic
resolution in a lens-free and compact form48. Phase detection was
achieved by ﬁrst shearing the incoming light into signal and reference
optical beams, and then interferometrically combining them in a
collinear common-path geometry. The corresponding beams are
quasi-overlapped and thus subjected to similar environmental instabil-
ities, leading to reduced noise. Measurements on transparent sub-
strates showed the potential of the device, but the demonstrated
sensitivity was not sufﬁcient for biosensing applications.
In this paper, we present a new plasmonic phase-sensitive detection
platform for measuring protein biomarker microarrays with high
throughput. It consists of a speciﬁcally designed metal nanostructured
chip that enhances phase effects of near-ﬁeld light–matter interactions,
which are then detected at the far ﬁeld using a large FOV lens-free
differential interference contrast microarray (LIM) imager. The
plasmonic interaction increases the phase sensitivity of the previously
demonstrated48 LIM setup by more than one order of magnitude,
which is crucial for efﬁcient biomarker detection.
Figure 1a depicts the large-area plasmonic microarray plate,
sandwiched between two polarizer (P), P1 and P2, and Savart plate
(SP), SP1 and SP2, pairs. The output from a collimated LED source is
split by SP1 into two orthogonally polarized beams sheared with
respect to each other (shear distance is 25 μm) that traverse the
microarray plate. The two sheared beams are recombined by SP2 and
interfered by P2, which is orthogonal to P1. This optical design allows
for the projection of minute topographical changes, enhanced by the
plasmonic interaction, onto a CMOS image sensor (~30 mm2).
Consequently, any phase difference between the two beams are
mapped over the entire sensor chip. In Figure 1a, we show a CMOS
image of the experimentally measured optical path difference (OPD)
map from a plasmonic chip patterned with arrays of 10 nm thin silica
(SiO2) layer. In order to emphasize the ﬂexibility of our method in
recognizing microspots with different diameters and interspot dis-
tances, we designed this pattern where the diameter of the spots
decrease from center to edge (350–50 μm), as well as the spacings in
between them (min 25 μm). The corresponding OPD contrast from
the microarrayed silica spots is clearly observed (Supplementary
Fig. 4S). The OPD maps are computed using multiple interferograms
collected at different SP1 tilt positions controlled by a stepper motor
and applying a phase-shifting interferometry method.
For the ﬁrst time, we exploit the sharp phase transitions at the
resonances of plasmonic gold nanohole arrays (Au-NHAs)49, instead
of the most commonly used amplitude-sensitive approach and
demonstrate high-throughput biosensing using the LIM imager. The
microarray plate, consisting of uniformly nanostructured Au-NHAs
over the entire sensor surface, is fabricated on robust glass wafers
using high-throughput and low-cost deep-ultraviolet lithography. Such
scalable and robust manufacturing techniques are necessary for
disposable and affordable biosensors. Figure 1b shows a 4ʺ wafer
comprising 50 Au-NHA chips (1 cm×1 cm). To characterize the
proposed plasmonic phase-sensitive detection platform, we ﬁrst
probed it using dielectric thin ﬁlms of amorphous silica (Figure 1c
and 1d), and showed that atomically thin (angstrom-level) topogra-
phical changes in a microarray setting with potentially millions of
protein biomarker spots can be detected. Subsequently, to validate the
platform as a biosensor, we created microarrays of protein solution
droplets on the plasmonic chips via low-volume liquid dispensers
(Figure 1e). The bioassays were carried out using a capillarity-based
disposable microﬂuidic platform, which enables on-chip, pumpless
ﬂuidic manipulation (Figure 1f). We experimentally extracted the
OPD sensitivity of our phase-sensitive reader as 9000 nm per refractive
index unit (RIU) and the minimum detectable refractive index change
as 5.7 × 10− 4 RIU, which is an order of magnitude higher than the
intensity-based imaging system values reported by Cetin et al28.
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Moreover, the LIM imager is highly integrated (portable) and built
with low-cost off-the-shelf consumer electronic and optic products,
such as CMOS image sensors and LEDs (Figure 1g), and it can also be
operated by a standard personal computer through a simple user
interface. The readout time for a single measurement is 30 s. All of
these features are essential for practical and rapid POC biosensing.
Detection principle
The plasmonic Au-NHAs retain the unique extraordinary transmis-
sion (EOT) phenomenon induced by the interplay of two resonance
coupling mechanisms in a classical asymmetric Fano-type spectral line
proﬁle22,50. Perpendicularly incident light generates in-plane surface
plasmon polariton sub-radiant modes satisfying the Bragg’s coupling
condition through wavevector matching of the grating’s momentum.
The sharp dark mode strongly couples to the subwavelength holes in
the Au ﬁlm and generates a bright radiant mode that scatters light into
the free space. These destructive and constructive near-ﬁeld interac-
tions are strongly dispersive and manifest themselves in the far-ﬁeld
intensity spectrum as multiple dips and peaks that constitute different
modes associated with either the supporting substrate or the top
medium. It is imperative for plasmonic biosensing that the sensing
mode be spectrally isolated from other modes as the refractive index of
the monitored medium changes51,52. A well-designed mode allows
sensing with different background media, such as air (nair= 1) or
water (nwater= 1.33), and ensures high sensitivity over a wide dynamic
range. In this work, we use the primary (−1, 0) EOT sensing mode of
the Au-NHA sensor (hole diameter= 200 nm and period= 600 nm)
and suppress the other substrate modes by increasing the thickness of
the Ti adhesion layer (10 nm) between the glass substrate and the
nanostructured Au ﬁlm. Figure 2b shows the numerically computed
intensity dispersion curve of the primary (−1, 0) EOT sensing mode,
which is spectrally well isolated. The slope of this continuous EOT
mode allows us to calculate the conventional bulk refractive index
sensitivity in the visible-to-near-infrared range as 615 nm per RIU
(Sbulk ¼ dlEOTdn , where λEOT is the transmission peak wavelength and n is
the refractive index of the top medium), which is in line with the
experimental ﬁndings reported in the literature22,51. In comparison to
the intensity, the phase response of the plasmonic resonances has not
been widely explored thus far. The incident light that couples to the
plasmonic surface experiences temporal retardation at the resonance
modes, resulting in sharp phase transitions in the far ﬁeld53, which can
be exploited for sensing the refractive index variations on sensor
surface. Figure 2c shows that phase dispersion curve exhibits the same
bulk sensitivity calculated on the intensity dispersion curve of
Figure 2b.
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Figure 1 Large FOV interferometric microarray imager (LIM) and experimental setup. (a) Collinear optical light-path conﬁguration of the LIM setup.
Collimated LED light beam is polarized (P1) and then sheared by a SP (SP1). This generates quasi-spatially overlapped and orthogonally polarized light
beams that traverse the plasmonic microarray plate and are subsequently recombined using a second SP (SP2) and interfered by a second polarizer (P2).
The interferogram is ﬁnally imaged by the CMOS sensor. The image shown on the schematic CMOS sensor is a real measured interferogram of a 10 nm-thin
silica (SiO2) pattern on a plasmonic chip. (b) Photograph of a wafer comprising 1 cm×1 cm plasmonic Au-NHA chips fabricated using high-throughput,
wafer-scale nanofabrication tools. (c, d) Artiﬁcially colored scanning electron microscopy images of 10 nm thin silica microarrays on uniformly patterned
plasmonic Au-NHAs. (e) Photograph of a plasmonic chip with 200 pl volume protein droplet microarrays formed using low-volume liquid dispensing tool.
(f) Disposable capillarity-based microﬂuidic platform assembled on the plasmonic microarray plate. (g) Portable interferometric microarray imager operated
through an interface running on an ordinary personal computer.
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In order to access the phase information from the plasmonic Au-
NHA sensor, we use the LIM imager introduced in Terborg et al48.
This imager offers precision and stability over a large FOV by
interfering sheared common-path collinear beams. The orthogonally
polarized and sheared beams, shown in Figure 2a as red and blue
columns, traverse the plasmonic sensor where they are both intensity
and phase modulated. As the Au-NHA plasmonic resonances are
polarization-independent28, the modulation functions vary only spa-
tially depending on whether the material to be detected is present or
absent at a given region on the sensor surface (In Figure 2a, the pink
region represents a microarray element to be detected). Speciﬁcally,
the beam that traverse the microarray element is referred to the signal
and is modulated by the ON functions; whereas, the beam that
traverse the bare sensor is referred to the reference and is modulated
by the OFF functions, as shown in Figure 2d. Note that the presence of
material on the sensor surface induces a redshift in the spectral
positions of both the intensity and phase modulation functions. When
the beams reach the second SP and polarizer, they are recombined and
interfered, and the topography of the microarray pattern on the sensor
surface is projected as interference contrast fringes on the CMOS
sensor. In Figure 2a, the green pixels of the CMOS sensor correspond
to regions where the sheared beams go through identical optical paths,
and therefore yield zero intensity after interference. Whereas the blue
and red pixels correspond to the regions where the beams are
modulated by different phase transmission functions (ϕON and
ϕOFF), resulting in a net intensity after interference. In contrast to
transparent substrates (that is, no plasmonic structure) where the
phase difference depends only on the thickness of the material and its
refractive index contrast with the medium, in our system the phase
difference is ampliﬁed by the plasmonic phase function, which results
in a sensitivity increase.
Unlike the previous intensity-based plasmonic biosensors, which
rely only on the spectral position of the EOT intensity peak, our
methodology uses the OPD between the signal and reference beams
(OPD=Δϕ/k, where k= λEOT/2π is the wavevector and Δϕ=
|ϕON−ϕOFF|). In our interferometric reader, this phase contrast value
(Δϕ) is extracted from multiple images recorded at different phase
bias using the computational phase-shifting interferometry
technique48. Figure 2e shows the numerically computed phase contrast
Δϕ (left axis) and OPD (right axis) as functions of the refractive index
difference (Δn= nmaterial− nmedium). The sensitivity of our system can
also be analytically stated as follows:
SPlOPD ¼ dðOPDÞ=dn ¼ Sbulk ´fder ´ lEOT=2p;
where ϕder= dϕ/dλ= 10 [deg/nm] at the EOT peak (indicated in
Figure 2d). The OPD sensitivity can, therefore, be numerically
estimated as 1.1 × 104 nm per RIU over a dynamic range of 0.025
RIU, which is sufﬁcient for biosensing applications. In our system, this
dynamic range is mainly deﬁned by the spectral shape of the
plasmonic mode, which correlates to the derivative of the phase
function (ϕder), as well as the spectrum of the illumination source.
Details on the plasmonic phase sensitivity (SPl-OPD) derivation are
presented in the Supplementary Information.
MATERIALS AND METHODS
Fabrication of Au-NHA plasmonic chips
Au-NHA chips are manufactured using wafer-scale, high-throughput
nanofabrication techniques on a robust transparent substrate in a
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Figure 2 Phase interrogation principle of LIM on plasmonic substrates. (a) Orthogonally polarized and symmetrically sheared, that is, partially overlapped,
beams (red and blue columns) are both intensity and phase modulated upon traversing the Au-NHA sensor, due to the plasmonic mode coupling. The
plasmonic phase and intensity modulation show spatial difference on the microarray spots (ON) with respect to the bare plasmonic surface (OFF). When the
light beams are recombined (that is, the shear is removed), they create fringe patterns indicated by blue and red regions on the CMOS sensor due to phase
differences induced by the distinct ON and OFF plasmonic phase modulation. (b, c) Numerically computed transmission intensity and phase dispersion of
the EOT mode plotted as a function of the refractive index (RI) of the top media. The redshift of the mode associated with the RI increase can be observed
both in the transmission intensity and phase plots (see contrast in the color maps). The bulk sensitivity (Sbulk) of the Au-NHAs (period 600 nm and
diameter=200 nm) is calculated as 615 nm per RIU. The LED source, with peak wavelength λpeak=656 nm, is also indicated on the plot. (d)
Representative intensity and phase modulation spectra associated with the ON and OFF regions with a RI difference (Δn) of 0.01. The phase derivative (ϕder)
corresponding to the EOT peak, which is a signiﬁcant parameter in phase interrogation, is marked on the plot. (e) Phase contrast (Δϕ) and the corresponding
OPD OPD ¼ Dfj j2p=l
 
between the ON and OFF regions as a function of Δn are calculated at the EOT resonance wavelength (λEOT) of the bare sensor. The
refractometric LIM sensitivity can be numerically calculated from the slope of the curve.
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single lithography step. First, Radio Corporation of America-cleaned
4-inch fused silica wafers are coated with Ti/Au (10/120 nm) using an
e-beam evaporator (Alliance-Concept EVA 760, Cran Gevrier,
France). The 10 nm-thick Ti layer not only enables the Au-adhesion
on the glass substrate but also suppresses the irrelevant surface modes
induced by the glass–Au interface. Therefore, only the (1, 0) EOT peak
can be monitored through a wide spectral interval, which is crucial for
wide dynamic sensing range. Next, the nanohole arrays (200-nm
diameter and 600-nm period) are patterned using a 248 nm deep-
ultraviolet stepper (ASML PAS 5500/300 DUV, Veldhoven, Nether-
lands). After resist development, the nanohole arrays are transferred
into the Ti/Au layer using an ion beam etching tool (Oxford
Instruments PlasmaLab 300 IBE, Abingdon, UK). The resist on the
surface is removed using oxygen plasma cleaning. Finally, after coating
with a layer of photoresist to protect the sensor surface, the 4-inch
wafer is diced into 1 cm×1 cm chips (Figure 1). The resist layer on
the chips is removed by a remover solvent followed by an oxygen
plasma exposure to ensure a uniformly clean sensor surface.
SiO2 microarray patterning
The Au-NHA and the transparent fused silica chips are post-patterned
to form SiO2 thin-ﬁlm microarrays. First, a single-step lithography is
performed using a bi-layer photoresist stack (top: AZ1512 HS, bottom:
LOR; MicroChemicals, Ulm, Germany). After resist development,
various thin SiO2 layers are evaporated on both Au-NHA chips and
their corresponding transparent controls using an e-beam evaporator
(Alliance-Concept EVA 760). Finally, a lift-off process in resist
remover solvent is applied, leaving a microarray of circular SiO2
thin-ﬁlm patterns (Figure 1a).
Spectroscopic chip validation
The fabricated Au-NHA chips are spectrally characterized using an
imaging spectrophotometer (IsoPlane 320, Princeton Instruments,
Trenton, NJ, USA), which is directly coupled to the outlet of a Nikon
(Tokyo, Japan) Eclipse-Ti inverted microscope. The transmission
spectra of the Au-NHA chips are recorded under normal white light
illumination and examined for the EOT peak position and bandwidth
validation.
Immobilizing bioreceptors on the sensor surface
To enable the biorecognition assays, the gold surface is modiﬁed with
detection proteins using noncovalent physicochemical adsorption.
First, protein A/G (recombinant fusion protein with protein A- and
protein G-binding sites) solution (500 μg ml− 1) in 10 mM acetate
buffer (pH 4) with 0.5% glycerol is deposited on the clean Au sensor
in a microarray format. A non-contact, low-volume liquid dispenser
(sciFLEXARRAYER S3, Scienion, Dortmund, Germany) is used to
create microarrays of protein A/G droplets (150 pl) with 100 μm
diameter and 250-μm period. After 1 h incubation, the chips are
washed in phosphate-buffered saline (PBS, pH 7.4) for 5 min under
constant agitation to remove excess proteins. The remaining area on
the bare Au surface is blocked by incubating the whole chip in 1 % v/v
bovine serum albumin (BSA) in PBS. Then, the chip is sequentially
incubated in mouse IgG solution (Abcam-ab37355, Cambridge, UK,
concentration 200 μg ml− 1) and its matching goat anti-mouse IgG
solution (Sigma-Aldrich-M2650, St Louis, MO, USA), each step
followed by PBS washing. Wet media measurements are performed
in PBS buffer, whereas for dry measurements, chips are rinsed in
deionized water to remove the salt residuals and dried with N2 after
each incubation step.
Fluidic platform and liquid media measurements
The liquid manipulation on the plasmonic chip is enabled by a
disposable microﬂuidic cartridge (microTEC Ges. für Mikrotechno-
logie mbH, Duisburg, Germany), fabricated using rapid micro product
development technology. The ﬂuid ﬂow is induced by capillary forces
without the need of an external pump. The cartridges are mass-
produced at low cost from poly(methyl methacrylate) using photo-
polymerization. The microﬂuidic cartridge design (dimensions:
14 mm×32 mm×1.01 mm) includes three parts: load chamber;
measurement chamber; and waste channel (Figure 1f). The load
chamber is open on the top side to access during the liquid insertion.
The measurement chamber is open on both sides, to which the
surface-functionalized plasmonic chip (bottom) and a glass slide (top)
are mechanically sealed. The waste channel is designed to have equal
volume (~70 μl) with the measurement chamber and contains two air-
release spots, positioned at the beginning and at the end of the
channel. Whereas the ﬁrst air release is initially kept open, the second
air release is sealed with a thin membrane facing the top side of the
cartridge.
For the liquid media measurements, ﬁrst, the analyte buffer with the
biomarker of interest is inserted into the load chamber. Driven by the
pressure equilibrium established with the open ﬁrst air release, the
ﬂuid is passively transferred from the loading well into the measure-
ment chamber by the capillary forces. At this point, the plasmonic
microarray plate patterned with capture antibodies is incubated with
the analyte solution. After the incubation, the rinsing buffer is added
into the load chamber and the second air release is punctured to
enable the transfer of analyte solution into the waste channel and
perform the ﬁnal readout.
Optical reader setup
The optical reader, with dimensions of 23 cm×21 cm×15 cm, is
composed of three modules: light source; optical assembly; and
electronics (Figure 1g).
The light source is an external LED block (Mightex), which
comprises four high-power LEDs that are coherently coupled into a
single multimode ﬁber. The LEDs are chosen to spectrally overlap with
the Au-NHA transmission peak positions: two in the red wavelength
region (625 and 656 nm) for dry and two in the near-infrared (850
and 870 nm) for wet medium measurements.
The optical assembly comprises optical elements that are mounted
to facilitate a vertical optical axis. First, the ﬁber-coupled light is
collimated using a parabolic mirror to enable uniform illumination
over the FOV. The collimated and coherent light beam passes through
the microarray plate mounted on the sample holder, which is
sandwiched between two sets of orthogonal P and SP pairs, and
terminates at the CMOS sensor (area= 4.2 × 5.7 mm2). Whereas all
optical elements are ﬁxed to the optical column, the top SP holder can
be tilted in the z direction. A step motor, whose rotation axis is shared
by a leveler with uneven radius, is used to push one side of the SP
holder to generate precisely controlled tilt angles of up to ± 2°.
RESULTS AND DISCUSSION
Mass manufacturing of plasmonic biosensors for large FOV interfero-
metric microarray imaging requires highly precise nanofabrication
techniques that produce chips with low variability. Speciﬁcally, the
reliability of our read-out method relies on Au-NHAs that exhibit
uniform plasmonic resonance properties over a large sensing ﬁeld
(30 mm2). Particularly, the variation of the EOT peak position (λEOT)
and its bandwidth should be sufﬁciently small not only within a chip
but also between chips fabricated on wafers in different batches. In
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order to investigate the effects of process variations on the plasmonic
resonance properties, we performed a statistical parameter analysis
over a sample set of spectral data, collected over 176 chips from four
wafers. We found the average EOT peak to be at 656± 1.11 nm and
the full width half max of the resonance peak to be 25± 1.33 nm.
Thus, we conclude that the high-throughput and large-scale fabricated
plasmonic Au-NHA chips are exceptionally robust and their optical
parameters are consistent. Further details on this statistical analysis are
given in the Supplementary Information and the fabrication details are
presented in the Materials and Methods section.
To evaluate the microarray detection capability of the phase contrast
LIM imager, large microarrays of silica layers with numerous
thicknesses were identically patterned on plasmonic Au-NHAs and
transparent (control) substrates. For clear visibility, representative
OPD maps of 4× 4 subsets from large microarrays with different silica
thicknesses are shown in Figure 3a. With our interferometric method,
a circular pattern on the plasmonic sensor is imaged as two crescent
shapes (color-coded as red and blue in Figure 3a), each with opposite
OPD values. The overall contrast is calculated from the difference
between these regions and, therefore, the experimentally acquired
OPD values are expected to be twice the numerically estimated ones.
The details on the OPD data extraction can be found in the
Supplementary Information. Figure 3b shows the average OPD
contrast data as a function of the silica thickness (bottom axis) and
effective refractive index difference, Δneff (top axis). Calculation of
Δneff from thin silica ﬁlms with different layer thicknesses is speciﬁed
in Supplementary Section. In Figure 3b, each data point represents the
average OPD contrast over 36 microarray elements and the baselines
correspond to contrasts measured in the absence of any silica layer.
We calculated the OPD sensitivity for silica thicknesses below 5 nm
from the slope of the ﬁtted curve (see left-most plots in Figure 3b). We
experimentally found that the plasmonic sensors exhibit signiﬁcantly
higher (~16× ) OPD sensitivity (2× SPl-OPD-Exp= 9000 nm per RIU)
when compared to the transparent controls (2× SCl-OPD-Exp= 550 nm
per RIU). This is in agreement with our numerical calculations
(Supplementary Information), where 2× SPl-OPD for plasmonic and
2× SCl-OPD for transparent substrates are estimated as 2.2 × 10
4 and
570 nm per RIU, respectively.
Plasmonic phase modulation also enables detection of atomically
thin layers, which cannot be resolved on transparent substrates, as
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demonstrated in Figure 3a (SiO2= 9 Å). In our experimental evalua-
tion using thin dielectric layers, we were limited by the deposition
tolerance of the evaporation system, which cannot deposit silica layers
thinner than 9 Å. Therefore, as the ultimate detection limit could not
be experimentally assessed, we estimated the minimum detectable
thickness to be 2.5 Å by interpolating the detection curve toward the
background baseline.
To evaluate the biosensing performance of our technology, we
demonstrate microarray detection of protein monolayer stacks in both
dry and wet media. A protein/antibody set with well-known high
afﬁnity was used in our experiments. Figure 4a shows the schematic
views of protein/antibody layers in their sequential formation and the
corresponding representative 4× 4 microarray OPD map readouts.
First, protein A/G solution (0.5 mg ml− 1) in 150 pl droplets was
spotted to deﬁne the capture layer of the microarray on bare
plasmonic chips. The remaining areas were then blocked with BSA
(1% v/v) to form an unreactive thin layer around the protein A/G-
covered microspots. Using the afﬁnity of the protein A/G to the
immunoglobulins (IgG), we tested the biosensing platform by adding
two layers of IgGs. As the topographic contrast is measured with
respect to the neighboring areas of the microspots, the BSA layer acts
as a negative control for the IgG detection. Figure 4a further depicts
the OPD maps that clearly indicate a contrast increase upon the
addition of the two subsequent IgG layers.
For illumination, we used two different LEDs with peaks at
wavelengths of 656 and 870 nm, which are aligned with the resonance
peaks of Au-NHAs in the dry and wet media, respectively. Figure 4b
shows the LEDs’ spectra and the measured transmission intensity
spectra of Au-NHA sensors using a conventional spectrophotometer
coupled to an inverted microscope. The typical spectra associated with
the bare and IgG2-coated sensor, in both wet and dry background, are
also presented in Figure 4b. As expected, the peak shift is more
signiﬁcant (~9 nm) in dry medium when compared to wet medium
(~4 nm), as the refractive index contrast that a biolayer has with air
(nair= 1) is higher than that with water (nwater= 1.33). This can also be
observed in the statistically collected OPD contrast data summarized
in the bar plots shown in Figure 4c, which show the average and the s.
d. (N= 36) after each biolayer formation. The magnitude of the OPD
contrast associated with each protein layer depends mainly on their
different molecular weights (A/G ~50 kDa and IgG ~150 kDa).
Additionally, the OPD contrast data acquired from the bare chip
3:980:6 nmð Þ in Figure 4c, together with the experimental OPD
sensitivity (9000 nm per RIU), can be used to identify the minimum
detectable RIU change (5.7× 10− 4 RIU). The results show that our
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method can be used for bioassays with multiple steps and the sensing
data can be obtained in both wet and dry media from a large set of
microarray spots.
Moreover, we performed a quantitative analysis and acquired a
calibration curve on the third layer of the protein stack, namely IgG2
obtained by incubating the IgG1 microarrays with different concen-
trations of IgG2 buffer solution. The data were acquired by subtracting
the OPD contrast from 36 microarray elements before and after the
IgG2 capture (Supplementary Fig. 5S) and it closely follows a
saturation curve, which is common in surface sensors due to limited
available capture sites. Our preliminary results show that our method
can detect a concentration of IgG2 as low as 500 ng ml− 1 and this
limit of detection is an order of magnitude higher than previously
reported values for intensity-based biosensor using Au-NHAs28.
Although this limit of detection is signiﬁcant, it can be further
enhanced, for example, if covalent surface functionalization methods,
such as the traditional thiol chemistry on Au surface, are used instead
of the physicochemical adsorption of capture proteins. Particularly, to
detect low-concentration analytes in real biological ﬂuids, such as
serum, a robust surface functionalization together with high-afﬁnity
capture agents are essential.
We also performed the protein detection experiments discussed
above on transparent glass plates with the same LIM imager in similar
experimental conditions reported before48, but the microarrays could
not be detected. Note that the Au-NHA substrates only enhance the
phase signal when material to be detected is within the reach of
plasmonically enhanced surface ﬁelds (o100 nm), contrary to the
transparent substrates where the total volume between the polarizers
are probed. Therefore, plasmonic substrates not only enhance the
biosensing signal from extremely small volumes near the surface but
also suppress the irrelevant fringes from the background media. This
emphasizes the importance of plasmonic phase enhancement for
biosensing applications.
Our biosensing platform enables simultaneous multiplexed data
collection from large microarrays thanks to its wide FOV, without the
need for image stitching or stage moving. In this work, we also used
computational diffraction correction methods48 to increase the lateral
resolution of the lens-free reader. In the LIM system, the lateral image
resolution and the shear distance of the SPs delimit the density of the
microarray. In our current reader (shear distance= 25 μm), we can
simultaneously monitor thousands of microarray elements in a
30 mm2 FOV, as shown in the sample pattern in Figure 1a. Our
calculations show that hardware and software improvements, such as
birefringence elements with smaller shear distance, detectors with
higher pixel density and improved diffraction correcting algorithms,
can further reduce the lateral resolution down to the CMOS pixel size,
that is, 4 μm. This would potentially allow simultaneous access to over
a million biomarkers thus enabling extraordinary multiplexing cap-
ability. Moreover, the integrated disposable ﬂuidic chip enables simple
analyte insertion and the straightforward user interface eliminates the
need for trained staff for on-site measurements. Additionally, the
interferometric imaging method extracts the sensing signal by
comparing it to reference signal from neighboring areas around the
microspot. This is a crucial property for biosensing as nonspeciﬁc
binding signals are inherently suppressed. Finally, while we only show
the end-point measurements, our platform can also perform kinetic
measurements when a ﬂuid insertion pump together with a compa-
tible microﬂuidic ﬂow cell is assembled to the chip.
CONCLUSIONS
In this work, we proposed and demonstrated a novel platform for
high-throughput and effective biosensing that exploits plasmonically
enhanced phase modulation in a compact, robust and portable
interferometric imager. Plasmonic phase modulation in a collinear
optical setup produces two-dimensional fringe maps on a large-area
consumer electronic CMOS imager of atomic-scale topographical
changes, without the need for intricate and expensive optical equip-
ment. Moreover, we achieved low-cost and robust manufacturing of
the nanostructured plasmonic sensor chips using deep-ultraviolet
lithography technology capable of uniformly nanopatterning an
entire 4ʺ wafer. Increasing the wafer size, or utilizing other wafer-
scale nanofabrication methods54, such as interference lithography,
could further reduce the cost per chip. We achieved high sensitivity in
this integrated nanophotonic system by leveraging the sharp transmis-
sion resonance of nanostructured plasmonic Au-NHA sensors. The
exceptional high-content microarray multiplexing can provide access
to extremely large data sets of biomolecular information acquired
from small quantities of biological samples, both saving time and
reducing cost of clinical testing. This disruptive technology can exploit
data science methodologies to cross-correlate the ‘big data’ that is
readily accessible from patients to transform the practice of medical
diagnostics and enable remote health monitoring. In summary, our
platform can have a signiﬁcant impact in POC rapid detection of life-
threatening diseases and advance next-generation health care, while
opening new avenues for exploration of nontrivial phase response of
nanophotonic systems for sensing applications.
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